Celltrion
068270.KS
#771
Rank
โ‚น2.176 T
Marketcap
โ‚น10,509
Share price
1.34%
Change (1 day)
-3.91%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.26

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น252.39. In 2022 the company made an earnings per share (EPS) of โ‚น245.70 a decrease over its 2021 EPS that were of โ‚น291.95.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.26-0.18%
2022โ‚น245.70-15.84%
2021โ‚น291.9512.77%
2020โ‚น258.8970.79%
2019โ‚น151.5815.63%
2018โ‚น131.09-33.13%
2017โ‚น196.05141.17%
2016โ‚น81.298.28%
2015โ‚น75.0811.28%
2014โ‚น67.4716.37%
2013โ‚น57.98-67.42%
2012โ‚น177.9784.22%
2011โ‚น96.6162.13%
2010โ‚น59.5980.61%
2009โ‚น32.99-559.63%
2008-โ‚น7.18-123.16%
2007โ‚น30.99